The Relationship of HER2 Copy Number Evaluated by Brightfield Dual In Situ Hybridisation DNA Assay and Pathologic Response to Neoadjuvant Treatment in HER2 Positive Breast Cancer-MedSci.cn

The Relationship of HER2 Copy Number Evaluated by Brightfield Dual In Situ Hybridisation DNA Assay and Pathologic Response to Neoadjuvant Treatment in HER2 Positive Breast Cancer

Neville, G; Feeley, L; Bennett, MW; O'Reilly, S; Corrigan, M; O'Connell, F; Browne, TJ

JOURNAL OF PATHOLOGY, 2017; 243 ( ): S22

科室
- - 订阅+
  - 更多科室
工具
服务